Kailera Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KLRA and other ETFs, options, and stocks.About KLRA
Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide.
KLRA Key Statistics
Stock Snapshot
With a market cap of 1.68B, Kailera Therapeutics(KLRA) trades at $13.31.
On 2026-11-08, Kailera Therapeutics(KLRA) stock traded between a low of $11.97 and a high of $13.31. Shares are currently priced at $13.31, which is +11.2% above the low and 0.0% below the high.
Kailera Therapeutics(KLRA) shares are trading with a volume of 733.26K, against a daily average of 810.57K.
During the past year, Kailera Therapeutics(KLRA) stock moved between $9.76 at its lowest and $28.23 at its peak.
During the past year, Kailera Therapeutics(KLRA) stock moved between $9.76 at its lowest and $28.23 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.